Currently holds a position at Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Syndax Pharmaceuticals Inc | Sept. 1, 2013 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2021-11-19 | 2021-11-18 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
30
-0.2%
18.03541 USD |
30 -0.2% | 18.03 | 541 USD | |
2021-11-19 | 2021-11-18 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
14,000
-46.7%
18.03252,452 USD |
14,000 -46.7% | 18.03 | 252,452 USD | |
2021-08-20 | 2021-08-18 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
15,635
-49.4%
15.75246,328 USD |
15,635 -49.4% | 15.75 | 246,328 USD | |
2021-05-20 | 2021-05-18 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
1,683
-9.5%
18.6531,385 USD |
1,683 -9.5% | 18.65 | 31,385 USD | |
2021-05-20 | 2021-05-18 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
11,926
-40.3%
18.65222,398 USD |
11,926 -40.3% | 18.65 | 222,398 USD | |
2021-03-03 | 2021-03-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
74
-0.5%
24.311,799 USD |
74 -0.5% | 24.31 | 1,799 USD | |
2021-03-03 | 2021-03-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
10,167
-38.7%
24.31247,182 USD |
10,167 -38.7% | 24.31 | 247,182 USD |